XTL Biopharmaceutica Correlations
XTLB Stock | USD 1.85 0.03 1.60% |
The current 90-days correlation between XTL Biopharmaceuticals and Xenetic Biosciences is -0.13 (i.e., Good diversification). The correlation of XTL Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
XTL Biopharmaceutica Correlation With Market
Significant diversification
The correlation between XTL Biopharmaceuticals Ltd and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding XTL Biopharmaceuticals Ltd and DJI in the same portfolio, assuming nothing else is changed.
XTL |
Moving together with XTL Stock
0.84 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.66 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.85 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.85 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
0.69 | PEPG | PepGen | PairCorr |
0.64 | RGNX | Regenxbio | PairCorr |
0.88 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.87 | BDTX | Black Diamond Therap | PairCorr |
0.66 | COLL | Collegium Pharmaceutical | PairCorr |
Moving against XTL Stock
0.77 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.74 | NAMS | NewAmsterdam Pharma | PairCorr |
0.69 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.62 | PHVS | Pharvaris BV | PairCorr |
0.54 | PLRX | Pliant Therapeutics | PairCorr |
0.46 | ESLAW | Estrella Immunopharma | PairCorr |
0.38 | LPTX | Leap Therapeutics | PairCorr |
0.33 | OPT | Opthea | PairCorr |
0.89 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.77 | SGMO | Sangamo Therapeutics Buyout Trend | PairCorr |
0.73 | AVTE | Aerovate Therapeutics | PairCorr |
0.68 | VREX | Varex Imaging Corp | PairCorr |
0.56 | ABEO | Abeona Therapeutics | PairCorr |
0.51 | AGIO | Agios Pharm | PairCorr |
Related Correlations Analysis
-0.03 | -0.39 | -0.81 | 0.38 | BNTC | ||
-0.03 | -0.06 | 0.21 | 0.19 | XBIO | ||
-0.39 | -0.06 | 0.54 | -0.8 | PRPH | ||
-0.81 | 0.21 | 0.54 | -0.5 | BVXV | ||
0.38 | 0.19 | -0.8 | -0.5 | BOSC | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between XTL Stock performing well and XTL Biopharmaceutica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze XTL Biopharmaceutica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
BNTC | 3.27 | 0.13 | 0.01 | 0.86 | 3.45 | 7.89 | 29.78 | |||
XBIO | 3.84 | 0.11 | 0.01 | 0.46 | 4.59 | 7.65 | 26.99 | |||
PRPH | 4.55 | (1.25) | 0.00 | 2.14 | 0.00 | 8.07 | 57.54 | |||
BVXV | 2.62 | (0.58) | 0.00 | 1.28 | 0.00 | 5.04 | 17.48 | |||
BOSC | 1.15 | 0.20 | 0.06 | 4.16 | 1.30 | 2.55 | 6.11 |
XTL Biopharmaceutica Corporate Management
Itay CPA | Chief Officer | Profile | |
Itay Weinstein | Chief Officer | Profile | |
Shlomo Shalev | CEO Director | Profile | |
Ronen Kantor | Company Sec | Profile |